China Biotech Services Holdings Limited
Simbol: 8037.HK
HKSE
0.305
HKDTržna cena danes
-2.3428
Razmerje P/E
0.0000
Razmerje PEG
293.79M
Kapaciteta MRK
- 0.03%
Donos DIV
China Biotech Services Holdings Limited (8037-HK) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 206.9 | 92.8 | 152.3 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -128.6 | 1.8 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 39.2 | 768.5 | 117.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 9.3 | 18.7 | 4.7 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 5.8 | 4.8 | 3.1 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 261.2 | 884.8 | 277.8 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 124.2 | 128.9 | 105.5 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 107.2 | 110.1 | 120.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 69.8 | 67.3 | 80.9 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 177 | 177.4 | 201.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 56.9 | 227.7 | 120.3 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 57.6 | -227.7 | 0 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | -14.6 | 279.5 | 1.8 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 401.2 | 585.7 | 429 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 5.8 | 206.4 | 16.1 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 94.7 | 16.6 | 63.6 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 3.7 | 242 | 85.2 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.7 | 65.2 | 3.6 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -5.7 | 0 | -9.9 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 58.6 | 325.2 | 23.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 12.2 | 95.3 | 13.5 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.7 | 20.3 | 11.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 171.6 | 644 | 240.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 96.3 | 96.3 | 96.3 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -310.8 | -209.9 | -475.1 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 186.5 | 225.6 | 283.5 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 490.7 | 490.7 | 490.7 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 462.8 | 602.7 | 395.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 28 | 223.8 | 70.5 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 490.7 | 826.5 | 465.9 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 56.9 | 99.2 | 122 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 100.4 | 81.8 | 67.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -106.5 | -11 | -83.4 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -95.4 | 862.8 | 180.7 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 55.6 | 66.4 | 68.1 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 381.7 | 0 | 7.8 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 1.9 | 2 | 5.2 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 494.8 | -433.3 | -225.5 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | 729.9 | -656.4 | -64.9 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -2.2 | -14 | -2.4 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | -232.9 | 237.1 | -158.3 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -645.9 | -15.2 | 4.2 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 7.5 | -6.5 | 0.5 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -51.8 | -0.5 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0.1 | 4.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -128.4 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -55.4 | -256.3 | -8.1 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -8.2 | -52.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.6 | -3 | -4.3 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -9.6 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -156 | -270.8 | -210.1 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -149.4 | -282 | -266.6 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2.2 | -2.3 | 0.2 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 114.1 | -57.8 | -234 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 206.9 | 92.8 | 150.6 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 92.8 | 150.6 | 384.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 192.6 | 482.7 | 40.5 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 129.7 | 413 | 28.3 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 212 | 1851.5 | 623.8 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 177.7 | 750.6 | 265.7 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 34.3 | 1101 | 358 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 158 | 251.5 | 168.8 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 335.7 | 1002.1 | 434.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 3.7 | 0.2 | 0 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 55.6 | 58.4 | 68.1 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | -123.7 | 851.7 | 189.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -134.3 | 862.8 | 180.7 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -1.3 | 157.3 | 48.1 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | -95.4 | 705.6 | 132.6 |
Pogosto zastavljeno vprašanje
Kaj je China Biotech Services Holdings Limited (8037.HK) skupna sredstva?
China Biotech Services Holdings Limited (8037.HK) skupna sredstva so 662362000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.100.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.200.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.535.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.796.
Kaj je China Biotech Services Holdings Limited (8037.HK) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -95447000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 100396000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 158009000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.